BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32351000)

  • 1. Sponsorship of oncology clinical trials in the United States according to age of eligibility.
    Neel DV; Shulman DS; Ma C; Bourgeois F; DuBois SG
    Cancer Med; 2020 Jul; 9(13):4495-4500. PubMed ID: 32351000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
    Roumiantseva D; Carini S; Sim I; Wagner TH
    Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis.
    Addeo A; Weiss GJ; Gyawali B
    JAMA Netw Open; 2019 May; 2(5):e193684. PubMed ID: 31074821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of industry sponsorship on the acceptance of abstracts and their publication.
    McLennan M; Leong FC; Steele A; Harris J
    Am J Obstet Gynecol; 2008 May; 198(5):579.e1-4. PubMed ID: 18455539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov.
    Ehrhardt S; Appel LJ; Meinert CL
    JAMA; 2015 Dec; 314(23):2566-7. PubMed ID: 26670975
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
    Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
    Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
    Gresham G; Meinert JL; Gresham AG; Meinert CL
    JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Ophthalmology Trials Registered in ClinicalTrials.gov, 2007-2018.
    Turner B; Rajeshuni N; Tran EM; Ludwig CA; Tauqeer Z; Weeks B; Kinde B; Pershing S
    Am J Ophthalmol; 2020 Mar; 211():132-141. PubMed ID: 31730839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.
    Goswami ND; Tsalik EL; Naggie S; Miller WC; Horton JR; Pfeiffer CD; Hicks CB
    Trials; 2014 Jan; 15():31. PubMed ID: 24450313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
    Liu X; Zhang Y; Li WF; Vokes E; Sun Y; Le QT; Ma J
    JAMA Netw Open; 2021 May; 4(5):e2110438. PubMed ID: 34028549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective.
    Ataman OU; Sambrook SJ; Wilks C; Lloyd A; Taylor AE; Wedge SR
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e447-54. PubMed ID: 22819210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of pediatric cardiovascular clinical trials registered on ClinicalTrials.gov.
    Hill KD; Chiswell K; Califf RM; Pearson G; Li JS
    Am Heart J; 2014 Jun; 167(6):921-9.e2. PubMed ID: 24890544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry sponsorship in trials on fluoride varnish or gels for caries prevention.
    Reda S; Elhennawy K; Meyer-Lückel H; Paris S; Schwendicke F
    Community Dent Oral Epidemiol; 2017 Aug; 45(4):289-295. PubMed ID: 28169445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sponsorship and Funding for Gene Therapy Trials in the United States.
    Kassir Z; Sarpatwari A; Kocak B; Kuza CC; Gellad WF
    JAMA; 2020 Mar; 323(9):890-891. PubMed ID: 32125392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sponsorship of clinical trials related to the spine: Trends over time and comparative analysis of trial characteristics by sponsorship type.
    Caruana DL; Jiang W; Elaydi A; Grauer JN
    N Am Spine Soc J; 2024 Mar; 17():100296. PubMed ID: 38130466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
    Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
    J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Radiotherapy Trials Compared With Other Oncological Clinical Trials in the Past 10 Years.
    Liu X; Zhang Y; Tang LL; Le QT; Chua MLK; Wee JTS; Lee NY; O'Sullivan B; Lee AWM; Sun Y; Ma J
    JAMA Oncol; 2018 Aug; 4(8):1073-1079. PubMed ID: 29799987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spine device clinical trials: design and sponsorship.
    Cher DJ; Capobianco RA
    Spine J; 2015 May; 15(5):1133-40. PubMed ID: 25637470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance with results reporting at ClinicalTrials.gov.
    Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
    N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.